LncRNA Information | |||||
---|---|---|---|---|---|
ID | EL0090 | Name | AC073284.4 | Aliases | N/A |
Species | Homo sapiens | Chromosome | N/A | Start site | N/A |
End site | N/A | Chain | N/A | Exon NO. | N/A |
Assembly | N/A | Class | lncRNA | NCBI accession | N/A |
Ensembl | N/A | Sequence | N/A | Peptide-related | N/A |
CircRNA | N/A | Exosomal | N/A | Structure | N/A |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Drug/chemo/stress | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | ||
breast cancer | paclitaxel | dual-luciferase reporter gene assay | paclitaxel-resistant breast cancer cells | down-regulated | interaction | Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells. | 31215650 |
Interaction | |||||||||
---|---|---|---|---|---|---|---|---|---|
Interaction target | Level of interaction | Type of interaction | Methods | Description | PMID | ||||
miR-18b-5p | RNA-RNA | binding | N/A | AC073284.4 could directly bind to miR-18b-5p and relieve the suppression for dedicator of cytokinesis protein 4 (DOCK4). | 31215650 | ||||
Display: |
|